| |
NATAP is distributing this survey for a group that would like to assess the need for new ARTs for patients who cannot be virally suppressed with currently available ART options
|
| |
| |
New HIV medications have allowed most patients to suppress their HIV. However viral load in some patients--despite good adherence--cannot be suppressed with commercially-available medicines.
Please help us estimate the number of patients in the United States that have one or no commercially available ARV treatment options by taking a few minutes to answer this survey. Please forward it to other physicians if you can.
This short 3-minute survey will provide very important information to a team of physicians, treatment advocates, the FDA, and researchers who are reviewing the current needs for expanded access programs of HIV investigational medications.
http://www.surveymonkey.com/s.aspx?sm=3ORwHUdFsigH6ZjfcpSOYA_3d_3d
|
|
| |
| |
|
|
|
